BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21951916)

  • 1. Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer.
    Xia ZK; Yuan YC; Yin N; Yin BL; Tan ZP; Hu YR
    Dis Esophagus; 2012 Jul; 25(5):427-36. PubMed ID: 21951916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration.
    Betapudi V; Licate LS; Egelhoff TT
    Cancer Res; 2006 May; 66(9):4725-33. PubMed ID: 16651425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA.
    Huang Y; Arora P; McCulloch CA; Vogel WF
    J Cell Sci; 2009 May; 122(Pt 10):1637-46. PubMed ID: 19401332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
    Li Y; Friedmann DR; Mhatre AN; Lalwani AK
    Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
    Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
    Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of mice and men: Relevance of cellular and molecular characterizations of myosin IIA to MYH9-related human disease.
    Even-Ram S; Yamada KM
    Cell Adh Migr; 2007; 1(3):152-5. PubMed ID: 19262128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.
    Pecci A; Ma X; Savoia A; Adelstein RS
    Gene; 2018 Jul; 664():152-167. PubMed ID: 29679756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.
    Schramek D; Sendoel A; Segal JP; Beronja S; Heller E; Oristian D; Reva B; Fuchs E
    Science; 2014 Jan; 343(6168):309-13. PubMed ID: 24436421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro].
    Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
    Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility.
    Hosono Y; Usukura J; Yamaguchi T; Yanagisawa K; Suzuki M; Takahashi T
    Biochem Biophys Res Commun; 2012 Nov; 428(1):173-8. PubMed ID: 23068101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Animal models of MYH9 disorders].
    Suzuki N; Kunishima S; Naoe T; Matsushita T
    Rinsho Ketsueki; 2013 Nov; 54(11):2031-7. PubMed ID: 24305535
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion.
    McMichael BK; Wysolmerski RB; Lee BS
    J Biol Chem; 2009 May; 284(18):12266-75. PubMed ID: 19269977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-muscle myosin II is an independent predictor of overall survival for cystectomy candidates with early-stage bladder cancer.
    Xiong D; Ye YL; Chen MK; Qin ZK; Li MZ; Zhang H; Xu LH; Xu ZZ; Zeng MS
    Oncol Rep; 2012 Nov; 28(5):1625-32. PubMed ID: 22895805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis.
    Sano M; Aoyagi K; Takahashi H; Kawamura T; Mabuchi T; Igaki H; Tachimori Y; Kato H; Ochiai A; Honda H; Nimura Y; Nagino M; Yoshida T; Sasaki H
    Int J Oncol; 2010 Feb; 36(2):321-30. PubMed ID: 20043065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated expression of the cyclase-associated protein 1 (CAP1) reduces migration in esophageal squamous cell carcinoma.
    Li M; Yang X; Shi H; Ren H; Chen X; Zhang S; Zhu J; Zhang J
    Jpn J Clin Oncol; 2013 Sep; 43(9):856-64. PubMed ID: 23904342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate.
    Morimura S; Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2011 Jan; 404(3):834-40. PubMed ID: 21184743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Li JY; Ma X; Zhang CB
    Int J Clin Exp Pathol; 2014; 7(11):7938-44. PubMed ID: 25550835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.